Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00080080
Status:
COMPLETED
Last Update Posted:
2007-06-08
First Post:
2004-03-23
Brief Title:
Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer
Sponsor:
Point Therapeutics
Organization:
Point Therapeutics
Organization Data
Organization:
Point Therapeutics
Class:
INDUSTRY
Study ID:
PTH-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Point Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None